A nurse receives three doses of hepatitis B vaccine produced by recombinant DNA technology in yeast. Months later her own plasma cells are making antibodies against the surface antigen of the virus, and the vaccine never gave her hepatitis. Which statement best explains why this vaccine is both safe and protective?